Innovation, quality care and international best practice
Eurolab began in 2011 with a commitment to bring down the costs of cancer treatment for cancer patients in South Africa and make cancer care more affordable. In achieving this, the company has focused on introducing innovation into South Africa’s cancer care environment to offer more cancer patients more options for treatment and recovery. This journey is far from over, and we are continually exploring strategies to introduce new products and programmes into the South African market.
“We believe that every cancer patient deserves the best chance of treatment success.” – Lynne Du Toit, Eurolab Group CEO.